WASHINGTON (AP) — Approvals for first-of-a-kind drugs climbed last year, pushing the annual tally of new U.S. drugs to its highest level in 19 years.
See the original post here:
First-of-a-kind drug approvals continued rise in 2015
WASHINGTON (AP) — Approvals for first-of-a-kind drugs climbed last year, pushing the annual tally of new U.S. drugs to its highest level in 19 years.
See the original post here:
First-of-a-kind drug approvals continued rise in 2015